ArticleScientific reports2025
The IL-36γ/PEDF/PPARγ signalling pathway plays an anti-inflammatory role in Candida albicans keratitis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic Potential of Isoniazid in Inflammatory Skin Diseases: A Review.Clinical, cosmetic and investigational dermatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fungal keratitis caused by Candida albicans (CA) is a common, disabling eye disease with a complex immune response system, affecting diagnosis, treatment, and prognosis. The specific regulatory roles and interactions of IL-36γ and pigment epithelium-derived factor (PEDF) in this disease remain largely unclarified. Additionally, the influence of miR-204-5p on the expression and anti-inflammatory functions of IL-36γ and PEDF in CA keratitis is insufficiently explored. Therefore, research focused on understanding the disease's pathogenesis and immune regulation. Human corneal epithelial cells treated with heat-killed CA showed anti-inflammatory responses from IL36γ and PEDF, confirmed via western blot, PCR, and ELISA. Transfection of small interfering RNA and recombinant protein granules showed PEDF exerts immunoprotected regulatory mechanisms by inhibiting NF-κB via PPARγ. Analysis of multiple miRNA target gene prediction databases and literature revealed that miR-204-5p is differentially expressed in fungal keratitis. PCR and dual luciferase reporter assays confirmed that miR-204-5p directly binds to PEDF mRNA, negatively regulating IL36γ and PEDF expression. Consequently, both PEDF and IL-36 γ exhibit anti-inflammatory effects in CA keratitis. PEDF may inhibit the NF-κB signaling pathway through the PPAR γ pathway. In addition, miR-204-5p inhibits the mRNA expression of IL-36 γ and PEDF, exacerbating inflammation. This provides a theoretical basis for new methods and drug targets for the prevention and treatment of CA keratitis, and promotes the clinical application of IL-36 γ/PEDF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.